Literature DB >> 31773560

Is there a link between venous and arterial thrombosis? A reappraisal.

Paolo Prandoni1.   

Abstract

Whether there is a link between venous and arterial thrombotic disorders is still a matter of debate. They share common risk factors, such as old age, male sex and obesity. Endothelial dysfunction and inflammation are likely to play a role in determining the simultaneous involvement of the two vascular compartments. Unlike subclinical atherosclerosis, symptomatic complications of atherosclerosis such as myocardial infarction, ischemic stroke and atrial fibrillation are likely to predict the subsequent development of venous thromboembolic (VTE) complications. Patients with VTE, especially those with apparently unprovoked episodes, have a definitely increased risk of subsequent arterial thrombotic disorders. Drugs that reduce the risk of arterial thrombosis are likely to reduce the risk of venous thrombosis and vice versa. In particular, the direct oral anticoagulants have recently been shown to reduce the risk of both vascular disorders. In conclusion, recent evidence provides compelling evidence in support of the link between venous and arterial thrombosis. Future studies are needed to clarify the nature of this association, to assess its extent, and to evaluate its implications for clinical practice.

Entities:  

Keywords:  Aspirin; Atherosclerosis; Deep-vein thrombosis; Direct oral anticoagulants; Heparin; Ischemic stroke; Myocardial infarction; Pulmonary embolism; Residual vein thrombosis; Risk factors; Statins; Venous thromboembolism

Mesh:

Year:  2019        PMID: 31773560     DOI: 10.1007/s11739-019-02238-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  5 in total

1.  Padua prediction score and IMPROVE score do predict in-hospital mortality in Internal Medicine patients.

Authors:  Guido Giuseppe Arpaia; Alessandro Caleffi; Giuseppe Marano; Micaela Laregina; Giulia Erba; Francesco Orlandini; Claudio Cimminiello; Patrizia Boracchi
Journal:  Intern Emerg Med       Date:  2020-01-02       Impact factor: 3.397

2.  Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.

Authors:  Scott D Berkowitz; Rupert M Bauersachs; Michael Szarek; Mark R Nehler; E Sebastian Debus; Manesh R Patel; Sonia S Anand; Warren H Capell; Connie N Hess; Judy Hsia; Nicholas J Leeper; David Brasil; Lajos Mátyás; Rafael Diaz; Marianne Brodmann; Eva Muehlhofer; Lloyd P Haskell; Marc P Bonaca
Journal:  J Thromb Haemost       Date:  2022-03-07       Impact factor: 16.036

3.  GnRH receptor mediates lipid storage in female adipocytes via AMPK pathway.

Authors:  Xiaoyong Li; Xueyan Zhang; Zhaojun Shen; Zhengyun Chen; Hanzhi Wang; Xinmei Zhang
Journal:  Int J Med Sci       Date:  2022-08-15       Impact factor: 3.642

4.  The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study.

Authors:  Daniela Tormene; Franco Noventa; Elena Campello; Sabrina Gavasso; Michelangelo Marobin; Giacomo Turatti; Paolo Prandoni; Paolo Simioni
Journal:  Intern Emerg Med       Date:  2021-02-22       Impact factor: 3.397

5.  Cardiovascular events in cancer patients with bone metastases-A Danish population-based cohort study of 23,113 patients.

Authors:  Peter H Asdahl; Jens Sundbøll; Kasper Adelborg; Thomas B Rasmussen; Anouchka M Seesaghur; Rohini K Hernandez; Henrik T Sørensen; Alma B Pedersen
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.